Erez Law is interested in speaking with investors who may have suffered losses due to investments with former Ross, Sinclaire & Associates, LLC financial advisor Anthony Conti (CRD# 1447173). Conti has been registered with Boenning & Scattergood, Inc. in Carnegie, Pennsylvania since June 2017. Previously, Conti was registered with Ross, Sinclaire & Associates, LLC in Pittsburgh, Pennsylvania from 2009 to 2017.
Conti has been the subject of two customer complaints between 2016 and 2018, according to his CRD report:
- February 2018. “Claimant alleges that Ross, Sinclaire & Associates, LLC. withheld material information concerning the financial condition of an issuer from its sales force and claimant prior to sale. Investment was deemed to be unsuitable by the claimant because of the undisclosed material information and investor’s conservative risk tolerance.” The customer is seeking $307,955 in damages and the case is currently pending.
- October 2016. “Three clients of RSA commenced an arbitration claim against the Firm (RSA). The clients alleged that RSA misrepresented the safety and security of film tax credit notes purchased from the issuer, leading clients to believe their principal was not subject to significant risk. The clients allege that these misrepresentations and negligence caused the loss of principal.” The customer is seeking $2.2 million in damages and the case is currently pending.
Pursuant to FINRA Rules, member firms are responsible for supervising a broker’s activities during the time the broker is registered with the firm. Therefore, Ross, Sinclaire & Associates, LLC may be liable for investment or other losses suffered by Conti’s customers.
Erez Law represents investors in the United States for claims against brokers and brokerage firms for wrongdoing. If and have experienced investment losses, please call us at 888-840-1571 or complete our contact form for a free consultation. Erez Law is a nationally recognized law firm representing individuals, trusts, corporations and institutions in claims against brokerage firms, banks and insurance companies on a contingency fee basis.